Chou TC - Search Results

1

Biochemical, pharmacological, and phase I clinical evaluation of pseudoisocytidine.

Woodcock TM, Chou TC, Tan CT, Sternberg SS, Philips FS, Young CW, Burchenal JH. Woodcock TM, et al. Among authors: chou tc. Cancer Res. 1980 Nov;40(11):4243-9. Cancer Res. 1980. PMID: 7471064 Clinical Trial.

2

Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adults.

Warrell RP Jr, Chou TC, Gordon C, Tan C, Roberts J, Sternberg SS, Philips FS, Young CW. Warrell RP Jr, et al. Among authors: chou tc. Cancer Res. 1980 Dec;40(12):4546-51. Cancer Res. 1980. PMID: 7438089

3

Metabolism and effects of 5-(beta-D-ribofuranosyl)isocytosine in P815 cells.

Chou TC, Burchenal JH, Fox JJ, Watanabe KA, Chu CK, Philips FS. Chou TC, et al. Cancer Res. 1979 Mar;39(3):720-8. Cancer Res. 1979. PMID: 427759

4

Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.

Chou TC, Hutchinson DJ, Schmid FA, Philips FS. Chou TC, et al. Cancer Res. 1975 Jan;35(1):225-36. Cancer Res. 1975. PMID: 1109791

5

Phase I and clinical pharmacology study of trimetrexate administered weekly for three weeks.

Fanucchi MP, Walsh TD, Fleisher M, Lokos G, Williams L, Cassidy C, Vidal P, Chou TC, Niedzwiecki D, Young CW. Fanucchi MP, et al. Among authors: chou tc. Cancer Res. 1987 Jun 15;47(12):3303-8. Cancer Res. 1987. PMID: 2953412

6

Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.

Chou TC, Schmid FA, Feinberg A, Philips FS, Han J. Chou TC, et al. Cancer Res. 1983 Jul;43(7):3074-9. Cancer Res. 1983. PMID: 6189591

7

Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine.

Philips FS, Feinberg A, Chou TC, Vidal PM, Su TL, Watanabe KA, Fox JJ. Philips FS, et al. Among authors: chou tc. Cancer Res. 1983 Aug;43(8):3619-27. Cancer Res. 1983. PMID: 6305489 No abstract available.

8

Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.

Blumenreich MS, Chou TC, Andreeff M, Vale K, Clarkson BD, Young CW. Blumenreich MS, et al. Among authors: chou tc. Cancer Res. 1984 Feb;44(2):825-30. Cancer Res. 1984. PMID: 6692380

9

Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.

Blumenreich MS, Woodcock TM, Andreeff M, Hiddemann W, Chou TC, Vale K, O'Hehir M, Clarkson BD, Young CW. Blumenreich MS, et al. Among authors: chou tc. Cancer Res. 1984 May;44(5):2203-7. Cancer Res. 1984. PMID: 6713407

10

Activity of 2-fluoro-5-methylarabinofuranosyluracil against mouse leukemias sensitive to and resistant to 1-beta-D-arabinofuranosylcytosine.

Burchenal JH, Chou TC, Lokys L, Smith RS, Watanabe KA, Su TL, Fox JJ. Burchenal JH, et al. Among authors: chou tc. Cancer Res. 1982 Jul;42(7):2598-600. Cancer Res. 1982. PMID: 7083153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters